genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Ataxia
News
Potential New Source of Mutations Causing Neurodegenerative Disease
John Sterling
-
August 17, 2023
0
Sponsored
Proficiency with Larger Knockins
Kathy Vuksanaj
-
October 13, 2020
0
Featured
In $1.9B Alliance, Neurocrine to Develop Voyager Gene Therapies for Parkinson’s, Friedreich’s Ataxia
Alex Philippidis
-
January 29, 2019
0
Industry News
RaNA Therapeutics Acquires Shire’s mRNA Platform
GEN Staff Writer
-
January 4, 2017
0
Genome Editing
Intrexon Wraps Up Busy Month with Three Collaborations and an Acquisition
GEN Staff Writer
-
December 31, 2013
0
News
Disease Afflicting the Young May Shed Light on Alzheimer’s and Parkinson’s
GEN Staff Writer
-
October 28, 2013
0
Genome Editing
New Gene Therapy Method Finds Success
GEN Staff Writer
-
July 25, 2012
0
News
Santhera Shares Drop 35% as Friedreich Ataxia Drug Fails in Phase III
GEN Staff Writer
-
May 20, 2010
0
News
Santhera Implements Named Patient Program for Friedrich’s Ataxia Drug in Europe and Switzerland
GEN Staff Writer
-
August 31, 2009
0
News
Santhera’s Friedreich’s Ataxia Drug Fails in U.S. Phase III Trial
GEN Staff Writer
-
May 19, 2009
0
1
2
Page 1 of 2
Scroll Up
Scroll Up
